Key result
Genetic polymorphisms evaluated for bronchiolitis susceptibility did not reach genome-wide significance, although suggestive loci including rs269094 (OR 1.44) were identified.
Case-Control (n=2,045)
Yes
This first genome-wide examination of bronchiolitis genetics identified suggestive susceptibility loci, including an eQTL for KCND3, though no genome-wide significant associations were found.
Does not support genetic testing for bronchiolitis risk; leaves open validation of suggestive loci in larger cohorts.
Bronchiolitis is a major cause of hospitalization among infants. Severe bronchiolitis is associated with later asthma, suggesting a common genetic predisposition. Genetic background of bronchiolitis is not well characterized. To identify polymorphisms associated with bronchiolitis, we conducted a genome-wide association study (GWAS) in which 5,300,000 single nucleotide polymorphisms (SNPs) were tested for association in a Finnish–Swedish population of 217 children hospitalized for bronchiolitis and 778 controls. The most promising SNPs (n = 77) were genotyped in a Dutch replication population of 416 cases and 432 controls. Finally, we used a set of 202 Finnish bronchiolitis cases to further investigate candidate SNPs. We did not detect genome-wide significant associations, but several suggestive association signals (p < 10−5) were observed in the GWAS. In the replication population, three SNPs were nominally associated (p < 0.05). Of them, rs269094 was an expression quantitative trait locus (eQTL) for KCND3, previously shown to be associated with occupational asthma. In the additional set of Finnish cases, the association for another SNP (rs9591920) within a noncoding RNA locus was further strengthened. Our results provide a first genome-wide examination of the genetics underlying bronchiolitis. These preliminary findings require further validation in a larger sample size.
No takes yet. Share an insight, caveat, or question.
Pasanen et al. (2017) conducted a case-control in Bronchiolitis (n=2,045). Genetic polymorphisms (SNPs) vs. Controls without bronchiolitis was evaluated on Association of single nucleotide polymorphisms with bronchiolitis susceptibility (OR 1.44, 95% CI 1.22-1.70, p=1.5 x 10^-5). Genetic polymorphisms evaluated for bronchiolitis susceptibility did not reach genome-wide significance, although suggestive loci including rs269094 (OR 1.44) were identified.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: